J B Chemicals News

Newspaper advertisement - transfer of shares to IEPF

Prior public notice for equity shareholders of the Company with regard to convening the AGM through Video Conferencing (VC)/Other Audio Visual Means (OAVM)

Intimation of schedule of Analysts/Institutional investors meet

Allotment of Equity Shares on exercise of Stock Options pursuant to Employee Stock Option Scheme

The Nifty Pharma index closed 0.66 per cent up at 21826.8.

Allotment of Equity Shares on exercise of Stock Options pursuant to Employee Stock Option Scheme

Allotment of Equity Shares on exercise of Stock options pursuant to Employee Stock Option Scheme

Allotment of Equity Shares on exercise of Stock options pursuant to Employee Stock Option Scheme

Transcript of Investors/Analysts call

Audio recording of Investors/analysts call with Management

Newspaper advertisement pertaining to financial results for quarter and year ended on March 31, 2025

Format of Initial Disclosure to be made by an entity identified as a Large Corporate.

Appointment of Secretarial Auditor

Re-appointment of Non-Executive Independent Director

Appointment of Non-Executive Independent Director

Re-appointment of Statutory Auditors

Recommendation of Final Dividend of Rs. 7 (700%) per equity share of FV of Re. 1 each for FY 2024-25

Audited Standalone and Consolidated Financial Results for the year ended on March 31, 2025

Presentation

Press Release

Audited standalone and Consolidated financial results for the year ended on March 31, 2025 accompanied by Auditors' Report.

Intimation of schedule of Analysts/Institutional investors meet

Allotment of equity shares on exercise of stock options pursuant to Employee Stock Option Scheme

JM Financial maintains a buy call on J B Chemicals & Pharmaceuticals, setting a target price of Rs 2,225. The brokerage believes a ban on ranitidine products, including J B Chemical's Rantac, is unlikely despite concerns over NDMA levels. J B Chemicals, incorporated in 1976, is a Mid Cap company with a market cap of Rs 25050.02 crore.

Investors/analysts call with management

JB Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2025 ,inter alia, to consider and approve (i) the audited financial results for the quarter and year ended on March 31, 2025; and (ii) to consider and recommend dividend on equity shares of the Company, if any, subject to approval of shareholders.

Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018

Disclosure submitted to exchange on April 2, 2025 and exchange email dated April 11, 2025

Disclosure submitted to the exchange on April 2, 2025 and exchange email dated April 11, 2025

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for abrdn Asia Ltd

Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Receipt of Cautionary Letter

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Tau Investment Holdings Pte Ltd & PACs

The NSE Nifty index was trading 88.25 points up at 23575.1

Allotment of Equity shares on exercise of stock options pursuant to Employee Stock Option Scheme

USFDA inspection of Company''s API manufacturing facility - D9 at Panoli, Gujarat

USFDA inspection of Company''s manufacturing facility - T20 at Panoli, Gujarat

DJSI (Dow Jones Sustainable Index) ESG Score release

Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Receipt of Order

Allotment of equity shares on exercise of Stock Options pursuant to Employee Stock Option Scheme

Intimation of schedule of Analysts/ Institutional Investors meet